On-Q-ity is developing personalized medicine diagnostics that will improve the lives of cancer patients. Through proprietary circulating tumor cell (CTC) and biomarker technology , we are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. We invite companies with complementary technologies, innovative biomarkers, and special expertise in our field to explore partnering relationships. Academic associations help guide us in our research and expand our scientific knowledge. Researchers specializing in cancer biomarkers, circulating tumor cells, cancer biology, and personalized cancer care are encouraged to contact us. In addition, we welcome the opportunity to work with companies developing novel cancer therapies where we can advance the understanding of mechanisms of action, develop pharmaco-dynamic markers, patient stratification strategies to maximize chances of success, and companion biomarkers to optimize therapeutic efficacy and cost-effectiveness. Contact us today to learn more about the benefits of partnering with On-Q-ity.
View Top Employees from On-Q-ity IncWebsite | http://www.on-q-ity.com |
Revenue | $8 million |
Funding | $31 million |
Employees | View employees |
Address | 610 Lincoln St, Waltham, Massachusetts 02451, US |
Phone | (781) 895-8100 |
Industry | Biotechnology, Pharmaceuticals, Healthcare |
Competitors | 3D Signatures Inc, Amadix, Boston Life Sciences Inc, Cernostics, IncellDx |
SIC | SIC Code 274 Companies, SIC Code 27 Companies |
NAICS | NAICS Code 51 Companies, NAICS Code 511 Companies, NAICS Code 5111 Companies |
Looking for a particular On-Q-ity Inc employee's phone or email?
The On-Q-ity Inc annual revenue was $8 million in 2023.
On-Q-ity Inc is based in Waltham, Massachusetts.
The NAICS codes for On-Q-ity Inc are [51, 511, 5111].
The SIC codes for On-Q-ity Inc are [274, 27].